Fred Telling - 23 Jun 2022 Form 4/A - Amendment Insider Report for ORAGENICS INC (OGEN)

Role: Director
Signature: /s/ Mark A. Catchur, as Attorney-in-Fact for Frederick W. Telling
Issuer symbol: OGEN
Transactions as of: 23 Jun 2022
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 27 Jun 2022, 16:10:15 UTC
Date Of Original Report: 24 Jun 2022
Previous filing: 21 Jun 2022
Next filing: 02 Aug 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGEN	Non-Employee Director Option (Right to Buy)	Award	$0	+250,000		$0.000000	250,000	23 Jun 2022	Common Stock	250,000	$0.2950	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022.
F2	Due to a clerical error, the Form 4, as originally filed, incorrectly reported the option expiration date. The Form 4, as amended by this Form 4/A, correctly reports such information. No other changes have been made to the originally filed Form 4.